Wound Care Market to Reach US$ 25.4B by 2031 | CAGR 4.5% | North America Leads, Asia-Pacific Fastest Growing | Key Players: Smith & Nephew, Coloplast, ConvaTec, 3M

The global Wound Care Market reached US$ 18.5 billion in 2023 and is expected to reach US$ 25.4 billion by 2031, growing with a CAGR of 4.5% from 2024 to 2031., according to DataM Intelligence.

United States: Recent Industry Developments
✅ January 3, 2023: ConvaTec announced the US launch of ConvaFoam, a family of advanced foam dressings for various wound types.
✅ July 18, 2023: RedDress Medical launched ActiGraft PRO with G-Code reimbursement status for the US wound care market.
✅ North America (led by the US) holds the largest market share, driven by major players, increased product launches, approvals, and high prevalence of chronic wounds like diabetic foot ulcers (1.6 million affected annually in the US).

Japan: Recent Industry Developments
✅ Growth aligns with Asia-Pacific trends in chronic wound management and rising healthcare needs.
✅ Regional emphasis on advanced dressings and infection prevention solutions supports aging populations and diabetes-related wounds.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):
https://www.datamintelligence.com/download-sample/wound-care-market?sindhuri
(Single User Report pricing and subscription details available on request.)

Asia-Pacific: Rapid Industry Developments
✅ Asia-Pacific is the fastest-growing region, driven by rising prevalence of chronic wounds (e.g., diabetic foot ulcers), increasing healthcare infrastructure, and product innovations.
✅ October 10, 2022: Bengaluru-based Healthium Medtech (India) launched Theruptor Novo wound dressing portfolio for chronic wounds like diabetic foot ulcers and leg ulcers.
✅ June 13, 2023: Evonik's JeNaCell launched Epicite balance wound dressing for chronic wounds (venous/arterial leg ulcers, diabetic foot ulcers, pressure ulcers), distributed to hospitals and homecare.
✅ Growth fueled by high diabetes incidence (e.g., 4.54% in newly diagnosed type 2 diabetes in India), trauma cases, and expanding access to advanced care.

Mergers & Acquisitions
✅ May 10, 2023: LifeNet Health acquired Bioventus Inc.'s wound care division, adding products like TheraSkin to expand biologics and regenerative portfolio.
✅ July 7, 2023: Coloplast agreed to acquire Kerecis (Icelandic biologics-focused wound care company) for up to $1.3 billion, strengthening position in the growing US biologics sector.

New Product/Service Launch
✅ January 3, 2023: ConvaTec launched ConvaFoam advanced foam dressings in the US.
✅ July 18, 2023: RedDress Medical launched ActiGraft PRO in the US with reimbursement support.
✅ June 13, 2023: JeNaCell (Evonik) launched Epicite balance for chronic wounds.
✅ October 10, 2022: Healthium Medtech launched Theruptor Novo for chronic wound management.
✅ March 3, 2023: Bactiguard launched infection prevention solutions, including biocompatible wound care products, in the UK and Ireland.

Technological Advancements in the Market
✅ Advancements in advanced wound dressings (foam, hydrogel, alginate, film), biologics, and infection prevention coatings to improve healing, reduce infection risk, and manage exudate/inflammation.
✅ Focus on chronic wound management (diabetic foot ulcers, pressure ulcers, venous leg ulcers) with products like antimicrobial and regenerative solutions.
✅ Integration of reimbursement-friendly innovations and homecare-compatible dressings to address high costs and accessibility.

Buy now and enjoy discounts - limited-time offer!
https://www.datamintelligence.com/buy-now-page?report=wound-care-market?sindhuri

Funding Raised by Companies
✅ Growth driven by strategic acquisitions (e.g., Coloplast's $1.3B Kerecis deal) and R&D investments by major players in biologics and advanced therapies.

Market Dynamics & Key Insights
✅ Drivers: Rising prevalence of chronic wounds (e.g., diabetic foot ulcers affect 18.6 million globally annually, preceding 80% of lower extremity amputations in diabetes patients); increased product launches/approvals; trauma from accidents/disasters; aging population; strategies like acquisitions/partnerships.
✅ Restraints: High costs of advanced products (e.g., ActiGraft $1,710-$3,780 over 4 weeks due to raw materials/labor); affordability issues.
✅ COVID-19 Impact: Negative due to manufacturing disruptions and reduced access/availability.
✅ Opportunities: Growth in chronic wound management, biologics sector, homecare settings, and emerging markets.
✅ Diabetic foot ulcers dominate due to high prevalence and severity.

Segmentation
By Product
Advanced Wound Dressings, Surgical Wound Dressings, Traditional Wound Dressings, Film Dressings, Alginate Dressings, Hydrogel Dressings.
By Wound Type
Diabetic Foot Ulcers (significant share), Pressure Ulcers, Surgical & Traumatic Wounds, Venous Leg Ulcers, Burns, Other Wounds.
By End-User
Hospitals, Specialty Clinics, Home Care Settings, Others.

Regional Analysis
North America leads with the largest share, supported by major players, frequent launches/approvals, and high chronic wound burden.
Asia-Pacific is the fastest-growing region due to rising diabetes/trauma cases and healthcare expansion.
Europe maintains position with innovations and launches (e.g., in UK/Ireland).
Latin America, Middle East & Africa show emerging growth potential.

Speak to Our Analyst and Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/wound-care-market?sindhuri

Competitive Landscape
The market is fragmented with local and international players. Key companies include Smith & Nephew PLC, Mölnlycke Health Care AB, Baxter International Inc., Acelity L.P. Inc., Integra LifeSciences Holding Corporation, Coloplast A/S, Ethicon Inc., 3M, Medline Industries LP, ConvaTec Group, and others.
Players drive growth through product launches, acquisitions (e.g., Kerecis, Bioventus division), and advancements in advanced dressings and biologics.

Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us:
DataM Intelligence is a full-service market research and consulting firm, guiding organizations from initial insight to strategic implementation. We transform proprietary data, emerging trends, and market developments into agile, actionable solutions.
Our robust methodology powers a vast research database featuring 6,300+ syndicated and custom reports across 40+ industries. We have delivered strategic solutions to 200+ companies in 50+ countries, addressing the core research challenges that drive growth for our clients.

This release was published on openPR.